Boehringer Ingelheim SR Principal Pathologist, MolPath in RIDGEFIELD, Connecticut

Boehringer Ingelheim is an equal opportunity global employer who takes pride in maintaining a diverse and inclusive culture. We embrace diversity of perspectives and strive for an inclusive environment which benefits our employees, patients and communities.


Lead the Molecular Pathology group, including management of technical support staff and scientific oversight of methods development and transfer for Tissue Cross Reactivity studies. Oversees methods development and technology evaluation for other innovative tissue based endpoints/biomarkers using state-of-the science and novel histopathology and imaging techniques in support of nonclinical safety studies.

As an employee of Boehringer Ingelheim, you will actively contribute to the discovery, development and delivery of our products to our patients and customers. Our global presence provides opportunity for all employees to collaborate internationally, offering visibility and opportunity to directly contribute to the companies' success. We realize that our strength and competitive advantage lie with our people. We support our employees in a number of ways to foster a healthy working environment, meaningful work, diversity and inclusion, mobility, networking and work-life balance. Our competitive compensation and benefit programs reflect Boehringer Ingelheim's high regard for our employees

Duties & Responsibilities:

  • Responsible for methods development for tissue cross reactivity (TCR) or target tissue distribution (TTD) studies, including method selection, positive and negative control material selection and/or generation, and oversight of primary antibody labeling and characterization (if necessary)

  • Performs veterinary pathology evaluations for non-project related studies conducted by the Integrative Toxicology section and/or Research (e.g., animal models, safety biomarker assessment studies, phenotyping of transgenic animals, etc.), providing results in the form of clear technical reports

  • Responsible for evaluation, recommendation and methods development/validation for molelcular pathology endpoints (e.g., immunohistochemistry, in situ hybridization, laser capture microdissection, quantitative image analysis, etc.) for subsequent application to non-clinical safety studies conducted by NDS US

  • Recruits, trains and develops laboratory scientific staff

  • Complies with all applicable regulations and company policies; ensures that work performed in area of responsibility is conducted in a safe and compliant manner; completes all required training on time and maintains proper records in accordance with SOPs and policies

  • Demonstrates fiscal responsibility over laboratory operating budgets by making cost effective recommendations and decisions regarding the purchase of supplies and equipment and outsourcing of study work


  • Veterinary Medical Degree from an accredited institution (DVM, VMD, BVSc or equivalent) and PhD from an accredited institution, with board certification in Veterinary Anatomic Pathology (DACVP, DECVP or equivalent)

  • Seven plus (7+) years of experience in toxicological pathology (pharmaceutical industry or biotechnology preferred)

  • A minimum of four (4) years of laboratory management experience

  • Strong leadership, collaboration and strategic skills

  • Demonstrates a broad knowledge of field and in depth expertise in molecular pathology techniques (eg, immunohistochemistry, in situ hybridization, laser capture microdissection, quantitative image analysis, etc.); Hands on experience in methods development and/or image analysis algorithm generation preferred.

  • Appropriate level of understanding and practice of applicable regulations

  • Ability to communicate effectively both orally and in writing


Must be legally authorized to work in the United States without restriction.

Must be willing to take a drug test and post-offer physical (if required)

Must be 18 years of age or older

Our Culture:

Boehringer Ingelheim is one of the world’s top 20 pharmaceutical companies and operates globally with approximately 50,000 employees. Since our founding in 1885, the company has remained family-owned and today we are committed to creating value through innovation in three business areas including human pharmaceuticals, animal health and biopharmaceutical contract manufacturing. Since we are privately held, we have the ability to take an innovative, long-term view. Our focus is on scientific discoveries and the introduction of truly novel medicines that improve lives and provide valuable services and support to patients and their families. Employees are challenged to take initiative and achieve outstanding results. Ultimately, our culture and drive allows us to maintain one of the highest levels of excellence in our industry. We are also deeply committed to our communities and our employees create and engage in programs that strengthen the neighborhoods where we live and work. Boehringer Ingelheim, including Boehringer Ingelheim Pharmaceuticals, Inc., Boehringer Ingelheim USA, Boehringer Ingelheim Animal Health USA, Inc., Merial Barceloneta, LLC and Boehringer Ingelheim Fremont, Inc. is an equal opportunity and affirmative action employer committed to a culturally diverse workforce. All qualified applicants will receive consideration for employment without regard to race; color; creed; religion; national origin; age; ancestry; nationality; marital, domestic partnership or civil union status; sex, gender identity or expression; affectional or sexual orientation; disability; veteran or military status, including protected veteran status; domestic violence victim status; atypical cellular or blood trait; genetic information (including the refusal to submit to genetic testing) or any other characteristic protected by law.

Boehringer Ingelheim is firmly committed to ensuring a safe, healthy, productive and efficient work environment for our employees, partners and customers. As part of that commitment, Boehringer Ingelheim conducts pre-employment verifications and drug screenings.

Organization: US-BI Pharma/BI USA

Title: SR Principal Pathologist, MolPath

Location: Americas-United States-CT-Ridgefield

Requisition ID: 177379